Market Insights Health Pharmaceuticals Vaccines

Other Vaccines - Cyprus

Cyprus

The Other Vaccines market in Cyprus is projected to reach a revenue of US$7.43m in 2024.
It is expected to show an annual growth rate (CAGR 2024-2029) of 10.50%, resulting in a market volume of US$12.24m by 2029.
In the global comparison, United States is expected to generate the most revenue in this market, with US$24,730.00m in 2024.
Cyprus is experiencing a growing demand for other vaccines, driven by increased awareness and government initiatives.

Key regions: Australia, Brazil, United Kingdom, Europe, Canada

Market

Region

Region comparison

Currency

Analyst Opinion

Other Vaccines market in Cyprus has been experiencing significant growth in recent years. Cyprus has a relatively small population, but the demand for other vaccines has been on the rise.

Customer preferences: The demand for Other Vaccines in Cyprus is driven by the increasing awareness of the importance of preventive healthcare. The population is becoming more health-conscious and is willing to invest in vaccines to prevent illnesses. Additionally, the country's high elderly population has also contributed to the demand for Other Vaccines.

Trends in the market: The Other Vaccines market in Cyprus has been growing at a steady pace, and this trend is expected to continue. The market is dominated by multinational pharmaceutical companies, and there is a trend towards the development of new and more effective vaccines. The market is also witnessing an increase in the number of private clinics that offer vaccination services.

Local special circumstances: Cyprus has a well-developed healthcare system that provides universal healthcare coverage to its citizens. The government provides free vaccinations for some diseases, but there is a growing trend towards private vaccination services. The country's high elderly population has also contributed to the demand for Other Vaccines.

Underlying macroeconomic factors: Cyprus has a small but open economy that is heavily dependent on tourism and services. The country has been recovering from a financial crisis that occurred in 2013, and the economy has been growing steadily. The healthcare sector in Cyprus is also growing, and the government has been investing in healthcare infrastructure and services. The growing demand for Other Vaccines in Cyprus is a reflection of the country's improving economic conditions and the increasing awareness of the importance of preventive healthcare.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.